Novel Therapeutic Approach for Spinal Cord Injury Suggested

Administering FTY720 - an oral drug improves locomotor recovery in mice with spinal cord injury (SCI), shows study. The research suggests a possible new avenue to counteract the degeneration of the spinal cord in human SCI. The study will be published in the April 2012 issue of The American Journal of Pathology.

Beyond the initial tissue damage, much of the degradation of the spinal cord in SCI is due to a cascade of secondary injuries, including neuronal and glial apoptosis, inflammation, glial scar formation, local edema and ischemia, and oxidative stress. The aim of current SCI treatment is to counteract the mechanisms of secondary injury and prevent their pathological consequences, because central nervous system (CNS) neurons have very limited capacity to self-repair and regenerate.

Researchers from the Jichi Medical University School of Medicine and the Graduate School of Medicine at the University of Tokyo had previously shown that the concentration of the lysophospholipid mediator, sphingosine 1-phosphate (S1P), was significantly increased in the location of a contusion injury, triggering the migration of neural progenitor/stem cells to the site of the injury. They hypothesized that targeting S1P receptors may become a candidate therapy for various refractory central nervous system disorders, including SCI.

FTY720 acts as a broad S1P receptor modulator. Its efficacy in central nervous system disorders is believed to derive from immunomodulation. Researchers found that orally administering FTY720 to mice shortly after contusion SCI significantly improved motor function recovery. Importantly, they found that the therapeutic effects of FTY720 were not solely dependent on immune modulation. The administration of FTY720 induced lymphopenia, clearing lymphocytes from the blood, and reduced T-cell infiltration in the spinal cord. But it did not affect the early infiltration of neutrophils and activation of microglia, and it did not reduce plasma levels and mRNA expression of inflammatory cytokines in the spinal cord. Tests in mice with severe combined immunodeficiency (SCID mice) with SCI found that FTY720 significantly improved recovery of hind limb motor function.

"These data clearly indicate the importance of immune-independent functions of FTY720 in the amelioration of functional deficits after SCI in mice," explains lead investigator Yoichi Sakata, MD, PhD, Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University School of Medicine.

Dr. Sakata notes that S1P receptors exist in many types of cells and play a role in many cellular processes. "We observed that FTY720 decreased vascular permeability and astrocyte accumulation in injured spinal cord. These changes were also noted in SCID mice, suggesting they are not dependent on lymphocyte function. Increased vascular permeability can lead to destruction of the blood-brain barrier in spinal cord, and astrocyte accumulation is the main cellular component of glial scar after CNS injury. FTY720 might counteract these secondary injuries and thereby prevent their pathological consequences."

"Our data suggest that targeting S1P receptors with FTY720 is an attractive therapeutic approach for SCI," Dr. Sakata concludes. "However, further evaluation utilizing larger animals such as non-human primates will be necessary to confirm its efficacy in treating SCI. Further, strategies targeted at modulating the SIP concentration in injured CNS may lead to new therapeutic approaches towards repairing various CNS disorders."

Source: Eurekalert

Phantom Limb Syndrome

A phantom limb is a complex phenomenon involving a sensation that an amputated or a missing limb, or an organ, is still attached to the body.

Spinal Cord Injury - First Aid and Emergency Treatment Guide

A quick and simple First Aid guide on how to administer treatment for Spinal Cord Injury.

Surgery Within 24 Hours of Traumatic Cervical Spinal Cord Injury Results in Reduced Neural Tissue Destruction

Recent research has pointed out that patients who receive surgery less than 24 hours after a traumatic cervical spine injury have better clinical outcomes.

Revised International Standards for Neurological Classification of Spinal Cord Injury

The International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) have been revised in 2011 and published

Athletes Foot

Athlete’s foot (tinea pedis/ringworm of the foot) is a fungal infection of the feet.

Autonomic Dysreflexia

Autonomic dysreflexia is a condition that occurs in patients with spinal cord injuries especially in the T5 and T6 levels. This condition is characterized by hyper activity of the autonomic nervous system.

Back Pain at Workplace: Prevention and Exercises

Understanding the basics about our back and our posture is very important in preventing back pain and improving workplace productivity.

Cauda Equina Syndrome

Cauda equina syndrome is a serious condition that occurs due to the compression of the nerves and nerve roots at the lower end of the spinal cord.

Hemiplegia

Hemiplegia is a condition that is characterized by paralysis of one half of the body, usually due to a brain lesion on the opposite side. It may be congenital (cerebral palsy) or acquired later in life due to illness.

Spinal Cord Injury

Spinal cord injury is an injury to the spinal cord that results in temporary or permanent changes in its function.

Spinal Injury - Symptom Evaluation

Spinal Injury refers to damage to spinal cord that runs below the brain through the back. Injury to spinal cord is a severe injury as the damage is irreversible and it can be life-threatening.

Spondylolisthesis

Spondylolisthesis is a condition of the lower spine in which one of the bones of the vertebral column slips out of its proper place and slides over to the vertebra below it.